CHICAGOLAND SMILE GROUP NOW OFFERING ENHANCED ORAL CANCER SCREENINGS
Kim Fasula, Dr. Zasso and their team takes a stand against oral cancer using OralID™ Fluorescence Technology
(Chicago, IL) – (December 2019) Chicagoland Smile Group joined forces with Forward Science, the manufacturer of OralID™, to become a provider of the ID for Life™ Program. This initiative will promote early detection and public awareness of oral cancer. All Chicagoland dental offices will be offering enhanced oral cancer screenings using the OralID™ during scheduled appointments to new and current patients.
Oral Cancer incidences are unfortunately not rare and currently, the number of individuals diagnosed is on the rise. This year alone, approximately 53,000 will be diagnosed with oral cancer in the United States. Largely due to late stage discovery, one American dies from oral cancer every hour. Chicagoland Smile Group is one of many dental offices taking a stand against the Oral Cancer epidemic, providing education and screenings to their patients across the state of Illinois.
“I feel that dental providers serve as the first line of defense and have the greatest opportunity to positively impact early detection of oral cancer,” says Chicagoland Smile Group’s Director of Hygiene, Kim Fasula. “That being said, I feel strongly that Chicagoland Smile Group play an active role in making a difference through oral cancer education, awareness, and screenings using advanced technology. Forward Science has provided us with the tools to satisfy these goals and provide our patients with the highest level of care.”
Chicagoland’s Chief Dental Officer, Dr. Charles Zasso, recommends screening with the OralID™ oral cancer screening device in efforts to discover oral cancers in their earliest stages. Currently, 63% of oral cancers are found in late stages (stage III, IV), resulting in a 5-year survival rate of less than 50%. Finding these abnormalities in much earlier stages can increase the 5-year survival rate up to 80-90%. Those interested in receiving an oral cancer screening or learning more about this advanced technology implemented at all Chicagoland offices, visit the website, https://www.chicagolandsmilegroup.com/, to find your closest Chicagoland office and ask about OralID™.
About Forward Science
Forward Science is a privately held MedTech company based in Houston, Texas. OralID, Forward Science’s flagship product, is an award-winning oral cancer screening device that allows clinicians to visualize abnormalities that may not be seen under traditional white light examinations. With the success of OralID, Forward Science continued to focus on moving science forward in the oral healthcare industry by launching advanced diagnostic testing products (CytID, hpvID, phID, PathID) along with treatment options (SalivaMAX and SalivaCAINE). In addition to developing proprietary, state-of-the-art products, Forward Science has partnered with industry leaders to provide new and effective solutions to the dental community. Forward Science designs, develops, and manufactures their products in-house, ensuring the highest quality of standards coupled with superior customer service. Forward Science has quickly evolved into the industry leader for providing oral healthcare products worldwide.
To learn more about any of Forward Science’s products, please visit www.ForwardScience.com or call 855-696-7254.